|1.||Böger, Rainer H: 26 articles (09/2015 - 01/2002)|
|2.||Zoccali, Carmine: 23 articles (10/2015 - 01/2002)|
|3.||Maas, Renke: 23 articles (01/2014 - 02/2002)|
|4.||Teerlink, Tom: 21 articles (01/2014 - 04/2002)|
|5.||Tain, You-Lin: 20 articles (09/2015 - 04/2010)|
|6.||Schwedhelm, Edzard: 19 articles (09/2015 - 02/2004)|
|7.||Bode-Böger, Stefanie M: 17 articles (10/2015 - 01/2002)|
|8.||Kielstein, Jan T: 17 articles (10/2015 - 01/2002)|
|9.||Huang, Li-Tung: 16 articles (09/2015 - 04/2010)|
|10.||Tsikas, Dimitrios: 16 articles (09/2015 - 05/2003)|
10/01/2010 - "Plasma asymmetric dimethylarginine (ADMA) is a novel risk factor for atherosclerosis and has been observed to associate with endothelial function in cross-section studies. "
05/01/2009 - "Studies are in development to establish the true role of asymmetric dimethylarginine as a marker and mediator of atherosclerosis, with possible therapeutic applications. "
09/01/2015 - "FoxO1 regulates asymmetric dimethylarginine via downregulation of dimethylaminohydrolase 1 in human endothelial cells and subjects with atherosclerosis."
07/26/2012 - "Asymmetric dimethylarginine and vascular indices of atherosclerosis in patients after coarctation of aorta repair."
04/01/2012 - "Asymmetric dimethylarginine (ADMA) is a novel marker of endothelial dysfunction and atherosclerosis. "
01/01/2014 - "Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients."
06/01/2012 - "HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction."
07/01/2015 - "Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study."
01/01/2013 - "Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases. "
07/01/2012 - "Asymmetric dimethylarginine was decreased in pediatric sepsis and was inversely associated with inflammation and organ dysfunction. "
|3.||Cardiovascular Diseases (Cardiovascular Disease)
07/01/2015 - "The aim of the present study was to investigate the associations of cumulative inflammatory burden (assessed by serial measurements of inflammatory markers) and classical cardiovascular disease (CVD) risk factors with asymmetric dimethylarginine (ADMA) in a large prospective cohort of patients with established RA. "
07/01/2005 - "Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials."
06/12/2015 - "Elevated levels of asymmetric dimethylarginine (ADMA) correlate with risk factors for cardiovascular disease. "
09/01/2014 - "The role of asymmetric dimethylarginine in HIV-related cardiovascular disease has not been established. "
03/01/2014 - "Finally, this system is successfully exploited to develop a biosensor for detecting asymmetric dimethylarginine (ADMA), an endogenous molecule involved in cardiovascular diseases. "
|4.||Kidney Diseases (Kidney Disease)
01/01/2007 - "The aim of this study was to find out whether the beneficial effects of the renin-angiotensin-aldosterone system (RAS) blockage in chronic kidney disease (CKD) has any relation with the alteration of asymmetric dimethylarginine (ADMA) levels. "
08/01/2005 - "Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study."
10/01/2015 - "Does asymmetric dimethylarginine play a role in depression in chronic kidney disease patients?"
01/01/2014 - "Asymmetric dimethylarginine (ADMA) is a prognostic factor in patients with chronic kidney disease (CKD). "
01/01/2014 - "Asymmetric dimethylarginine and progression of chronic kidney disease: a one-year follow-up study."
07/01/2015 - "Asymmetric dimethylarginine reflects cumulative inflammatory burden in rheumatoid arthritis. "
03/01/2014 - "Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis."
01/01/2013 - "Determination of the diagnostic values of asymmetric dimethylarginine as an indicator for evaluation of the endothelial dysfunction in patients with rheumatoid arthritis."
01/01/2013 - "To determine whether demographic, inflammatory, and metabolic factors predict elevated asymmetric dimethylarginine (ADMA) levels in rheumatoid arthritis (RA). "
05/01/2012 - "Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis."
|1.||Nitric Oxide (Nitrogen Monoxide)
|5.||oxidized low density lipoprotein
|7.||Interleukin-6 (Interleukin 6)
|1.||Estrogen Replacement Therapy
|2.||Electric Countershock (Cardioversion)
|3.||Renal Dialysis (Hemodialysis)
|4.||Continuous Ambulatory Peritoneal Dialysis (CAPD)